Search

Search Constraints

You searched for: Author/Creator Heiland, Tim

Search Results

1. Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma. (30th July 2019)

3. CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3. (12th November 2021)

4. A New Experimental Polytrauma Model in Rats: Molecular Characterization of the Early Inflammatory Response. (29th February 2012)

5. A New Experimental Polytrauma Model in Rats: Molecular Characterization of the Early Inflammatory Response. (29th February 2012)

6. Ten-Step Minimally Invasive Spine Lumbar Decompression and Dural Repair Through Tubular Retractors. Issue 2 (1st April 2017)

7. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Issue 5 (April 2017)

8. A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3. Issue 1 (24th June 2021)